Efficacy of l-Ornithine l-Aspartate for the Treatment of Hepatic Encephalopathy and Hyperammonemia in Cirrhosis: Systematic Review and Meta-Analysis of Randomized Controlled Trials

This publication has 34 references indexed in Scilit:

• Meta-regression approximations to reduce publication selection bias
  Research Synthesis Methods, 2013
• A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy
  European Journal of Gastroenterology & Hepatology, 2011
• A double-blind, randomized, placebo-controlled trial of intravenous l-ornithine-l-aspartate on postural control in patients with cirrhosis
  Liver International, 2010
• l‐Ornithine‐l‐aspartate in the management of hepatic encephalopathy: A meta‐analysis
  Journal of Gastroenterology and Hepatology, 2009
• Issues in the selection of a summary statistic for meta‐analysis of clinical trials with binary outcomes
  Statistics in Medicine, 2002
• Quantifying heterogeneity in a meta‐analysis
  Statistics in Medicine, 2002
• Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998
  Hepatology, 2002
• Effect of l-ornithine-l-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial
  Gut, 2000
• Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: Results of a placebo-controlled, double-blind study
  Hepatology, 1997
• Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
  Controlled Clinical Trials, 1996